...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: For The Record

I bought "ZHCLF" (Zenith Capital Corp) stock on the OTC Market post April 8, 2013, Resverlogix Corp's spin-out of its subsidiary RVX therapeutics.

I have just received my Management Information Circular in connection with Zenith's Annual Meeting of Shareholders to be held on October 27, 2022. This confirms that the "ZHCLF" stock symbol trading on the OTC markets is in fact Zenith Capital Corp, as we know it.

 

Koo 

2
Sep 28, 2022 07:52AM
2
Sep 28, 2022 04:48PM
Share
New Message
Please login to post a reply